Hypersensitivity and in-stent restenosis in coronary stent materials.
Hu W, Jiang J.
Front Bioeng Biotechnol. 2022 Sep 15;10:1003322. doi: 10.3389/fbioe.2022.1003322. eCollection 2022.
Coronary intravascular brachytherapy for in-stent restenosis: A review of the contemporary literature.
Detloff LR, Ho EC, Ellis SG, Ciezki JP, Cherian S, Smile TD.
Brachytherapy. 2022 Sep-Oct;21(5):692-702. doi: 10.1016/j.brachy.2022.05.004. Epub 2022 Jun 17.
In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management.
Shafiabadi Hassani N, Ogliari LC, Vieira de Oliveira Salerno PR, Pereira GTR, Ribeiro MH, Palma Dallan LA.
Medicina (Kaunas). 2024 Mar 28;60(4):549. doi: 10.3390/medicina60040549.
In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases.
Zhang DM, Chen S.
Cardiol Res Pract. 2020 Oct 25;2020:8104939. doi: 10.1155/2020/8104939. eCollection 2020.
Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
Wallner K, Kearney KE, Kim M, Tiwana J, Elison D, Kim EY, Parvathaneni U, Lombardi WL, Phillips ML, Don C.
Catheter Cardiovasc Interv. 2022 Nov;100(5):759-762. doi: 10.1002/ccd.30399. Epub 2022 Sep 13.
Recent Advances in the Treatment of Coronary In-Stent Restenosis.
Sartore L, Gitto M, Oliva A, Kakizaki R, Mehran R, Räber L, Spirito A.
Rev Cardiovasc Med. 2024 Dec 6;25(12):433. doi: 10.31083/j.rcm2512433. eCollection 2024 Dec.
Diagnosis and management challenges of in-stent restenosis in coronary arteries.
Alraies MC, Darmoch F, Tummala R, Waksman R.
World J Cardiol. 2017 Aug 26;9(8):640-651. doi: 10.4330/wjc.v9.i8.640.
In-Stent Restenosis: Is the Future Bioresorbable?
Claessen BE, Feldman DN.
JACC Cardiovasc Interv. 2024 Aug 12;17(15):1837-1839. doi: 10.1016/j.jcin.2024.06.018.
Management of in-stent restenosis.
Alfonso F, Coughlan JJ, Giacoppo D, Kastrati A, Byrne RA.
EuroIntervention. 2022 Jun 3;18(2):e103-e123. doi: 10.4244/EIJ-D-21-01034.
Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis.
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Omer M, Saad M, Willson L, Monyak DJ, Sullivan P, Pershad A, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES.
Cardiovasc Revasc Med. 2021 Feb;23:28-35. doi: 10.1016/j.carrev.2020.08.035. Epub 2020 Aug 23.
